Chen Hui, Dziuba Natallia, Friedrich Brian, von Lindern Jana, Murray James L, Rojo Daniel R, Hodge Thomas W, O'Brien William A, Ferguson Monique R
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-0435, USA.
Virology. 2008 Sep 30;379(2):191-6. doi: 10.1016/j.virol.2008.06.029. Epub 2008 Aug 5.
HIV infection typically involves interaction of Env with CD4 and a chemokine coreceptor, either CCR5 or CXCR4. Other cellular factors supporting HIV replication have also been characterized. We previously demonstrated a role for CD63 in early HIV infection events in macrophages via inhibition by anti-CD63 antibody pretreatment. To confirm the requirement for CD63 in HIV replication, we decreased CD63 expression using CD63-specific short interfering RNAs (siRNA), and showed inhibition of HIV replication in macrophages. Surprisingly, pretreatment with CD63 siRNA not only silenced CD63 expression by 90%, but also inhibited HIV-1 replication in a cultured cell line (U373-MAGI) which had been previously shown to be insensitive to CD63 monoclonal antibody inhibition. Although the anti-CD63 antibody was previously shown to inhibit early HIV infection events only in macrophages, we now show a potential role for CD63 in later HIV replication events in macrophages and cell lines. Further delineation of the role of CD63 in HIV replication may lead to development of novel therapeutic compounds.
HIV感染通常涉及Env与CD4以及趋化因子共受体(CCR5或CXCR4)的相互作用。其他支持HIV复制的细胞因子也已得到表征。我们先前通过抗CD63抗体预处理的抑制作用,证明了CD63在巨噬细胞早期HIV感染事件中的作用。为了证实HIV复制中对CD63的需求,我们使用CD63特异性小干扰RNA(siRNA)降低了CD63的表达,并显示出对巨噬细胞中HIV复制的抑制作用。令人惊讶的是,用CD63 siRNA预处理不仅使CD63表达沉默了90%,而且还抑制了先前已证明对CD63单克隆抗体抑制不敏感的培养细胞系(U373-MAGI)中的HIV-1复制。尽管先前已证明抗CD63抗体仅在巨噬细胞中抑制早期HIV感染事件,但我们现在显示出CD63在巨噬细胞和细胞系中晚期HIV复制事件中的潜在作用。进一步阐明CD63在HIV复制中的作用可能会导致新型治疗化合物的开发。